Deutsche Bank AG Acquires 215,455 Shares of Owens & Minor, Inc. (NYSE:OMI)

Deutsche Bank AG grew its position in Owens & Minor, Inc. (NYSE:OMI - Free Report) by 77.0% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 495,111 shares of the company's stock after purchasing an additional 215,455 shares during the period. Deutsche Bank AG owned approximately 0.64% of Owens & Minor worth $6,471,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds also recently modified their holdings of OMI. Freestone Grove Partners LP acquired a new stake in Owens & Minor in the 4th quarter valued at approximately $5,125,000. Charles Schwab Investment Management Inc. grew its stake in shares of Owens & Minor by 13.6% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,305,043 shares of the company's stock worth $30,127,000 after acquiring an additional 276,807 shares in the last quarter. Norges Bank bought a new position in shares of Owens & Minor during the 4th quarter worth approximately $2,465,000. Kennedy Capital Management LLC grew its stake in shares of Owens & Minor by 15.5% during the 4th quarter. Kennedy Capital Management LLC now owns 1,216,859 shares of the company's stock worth $15,904,000 after acquiring an additional 163,184 shares in the last quarter. Finally, Gabelli Funds LLC raised its holdings in shares of Owens & Minor by 81.1% in the fourth quarter. Gabelli Funds LLC now owns 326,000 shares of the company's stock valued at $4,261,000 after purchasing an additional 146,000 shares during the last quarter. 98.04% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Owens & Minor

In related news, major shareholder Coliseum Capital Management, L purchased 354,901 shares of the firm's stock in a transaction that occurred on Monday, March 3rd. The shares were acquired at an average price of $9.19 per share, for a total transaction of $3,261,540.19. Following the purchase, the insider now owns 9,824,599 shares in the company, valued at approximately $90,288,064.81. This represents a 3.75% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In the last quarter, insiders have acquired 2,718,412 shares of company stock worth $24,495,308. Company insiders own 3.69% of the company's stock.

Owens & Minor Stock Performance

Shares of OMI traded down $0.42 during midday trading on Wednesday, reaching $6.88. The stock had a trading volume of 1,789,952 shares, compared to its average volume of 1,130,356. The company has a current ratio of 1.09, a quick ratio of 0.45 and a debt-to-equity ratio of 2.11. The firm has a 50 day simple moving average of $7.78 and a 200-day simple moving average of $10.50. The firm has a market cap of $531.82 million, a PE ratio of -10.59, a P/E/G ratio of 0.20 and a beta of 1.38. Owens & Minor, Inc. has a one year low of $6.07 and a one year high of $18.11.

Owens & Minor (NYSE:OMI - Get Free Report) last posted its quarterly earnings results on Saturday, May 10th. The company reported $0.23 EPS for the quarter, topping analysts' consensus estimates of $0.20 by $0.03. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. Owens & Minor's quarterly revenue was up .7% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.19 earnings per share. As a group, sell-side analysts anticipate that Owens & Minor, Inc. will post 1.51 EPS for the current year.

Owens & Minor announced that its Board of Directors has initiated a share repurchase program on Friday, February 28th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to buy up to 13.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's leadership believes its stock is undervalued.

Analysts Set New Price Targets

Several research analysts recently commented on OMI shares. UBS Group reduced their target price on shares of Owens & Minor from $25.00 to $13.00 and set a "buy" rating for the company in a report on Thursday, February 13th. JPMorgan Chase & Co. decreased their price objective on Owens & Minor from $14.00 to $10.00 and set an "underweight" rating for the company in a report on Monday, March 10th. Robert W. Baird lifted their target price on Owens & Minor from $10.00 to $11.00 and gave the company a "neutral" rating in a research report on Monday, March 3rd. Finally, Citigroup reduced their price target on Owens & Minor from $13.00 to $11.00 and set a "buy" rating for the company in a research report on Thursday, April 17th. Two analysts have rated the stock with a sell rating, three have assigned a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, Owens & Minor currently has an average rating of "Hold" and an average target price of $12.50.

About Owens & Minor

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.